A phase II trial of frontline capecitabine and bevacizumab in poor performance status and/or elderly patients with metastatic colorectal cancer.
J Geriatr Oncol
; 4(4): 302-9, 2013 Oct.
Article
in En
| MEDLINE
| ID: mdl-24472472
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Colorectal Neoplasms
/
Angiogenesis Inhibitors
/
Deoxycytidine
/
Antibodies, Monoclonal, Humanized
/
Fluorouracil
/
Antimetabolites, Antineoplastic
Type of study:
Clinical_trials
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Geriatr Oncol
Year:
2013
Document type:
Article
Country of publication:
Netherlands